FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

11506111000001104: Tiabendazole 500mg/5ml oral suspension sugar free 120 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
42267401000001116 Tiabendazole 500mg/5ml oral suspension sugar free 120 ml (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
42267501000001117 Tiabendazole 500mg/5ml oral suspension sugar free 120 ml en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tiabendazole 500mg/5ml oral suspension sugar free 120 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tiabendazole 500mg/5ml oral suspension sugar free 120 ml Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Tiabendazole 500mg/5ml oral suspension sugar free 120 ml Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Tiabendazole 500mg/5ml oral suspension sugar free 120 ml Is pack of Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension false Inferred relationship Existential restriction modifier
Tiabendazole 500mg/5ml oral suspension sugar free 120 ml Has active ingredient Tiabendazole false Inferred relationship Existential restriction modifier
Tiabendazole 500mg/5ml oral suspension sugar free 120 ml Has manufactured dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
Tiabendazole 500mg/5ml oral suspension sugar free 120 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tiabendazole 500mg/5ml oral suspension sugar free 120 ml VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Tiabendazole 500mg/5ml oral suspension sugar free 120 ml Has VMP Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension true Inferred relationship Existential restriction modifier
Tiabendazole 500mg/5ml oral suspension sugar free 120 ml Has specific active ingredient Tiabendazole true Inferred relationship Existential restriction modifier
Tiabendazole 500mg/5ml oral suspension sugar free 120 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Tiabendazole 500mg/5ml oral suspension sugar free 120 ml VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Mintezol 500mg/5ml oral suspension (Merck & Co. Inc) 120 ml Is a True Tiabendazole 500mg/5ml oral suspension sugar free 120 ml Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start